Skip to main content
. 2023 Jul 20;36(11):612–618. doi: 10.1093/ajh/hpad066

Figure 1.

Figure 1.

Subgroup analyses for placebo-corrected mean change from baseline to day 84 in SBP for Ocedurenone treatment groups (a: 0.25 mg, b: 0.5 mg) in intention-to-treat population. Abbreviations: eGFR, estimated glomerular filtration rate; LS Mean Diff, least squares mean difference; n1, number of patients on placebo; n2, number of patients on Ocedurenone 0.25 mg once daily; n3, number of patients on Ocedurenone 0.5 mg once daily; SBP, systolic blood pressure; UACR, urinary albumin-to-creatinine ratio; VS, versus.